Invention Grant
- Patent Title: Amorphous form of tetracyclic compound
-
Application No.: US15501267Application Date: 2015-08-07
-
Publication No.: US10344014B2Publication Date: 2019-07-09
- Inventor: Koji Shiraki , Tadanobu Nakayama , Tomoaki Ota
- Applicant: Chugai Seiyaku Kabushiki Kaisha
- Applicant Address: JP Tokyo
- Assignee: CHUGAI SEIYAKU KABUSHIKI KAISHA
- Current Assignee: CHUGAI SEIYAKU KABUSHIKI KAISHA
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2014-162899 20140808
- International Application: PCT/JP2015/072450 WO 20150807
- International Announcement: WO2016/021707 WO 20160211
- Main IPC: A61K9/10
- IPC: A61K9/10 ; A61K47/32 ; A61K47/38 ; C07D401/04 ; C07D401/10 ; A61K31/5377
Abstract:
An amorphous form of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile and a solid dispersion containing the amorphous form can be used extremely advantageously as drugs for oral administration.
Public/Granted literature
- US20170217927A1 AMORPHOUS FORM OF TETRACYCLIC COMPOUND Public/Granted day:2017-08-03
Information query
